Search

Your search keyword '"Lacasce, A. S."' showing total 25 results

Search Constraints

Start Over You searched for: Author "Lacasce, A. S." Remove constraint Author: "Lacasce, A. S." Publisher wiley Remove constraint Publisher: wiley
25 results on '"Lacasce, A. S."'

Search Results

2. MATURE RESULTS FROM A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN PLUS ADRIAMYCIN AND DACARBAZINE WITHOUT RADIATION IN NON‐BULKY LIMITED STAGE CLASSICAL HODGKIN LYMPHOMA

3. BRENTUXIMAB VEDOTIN WITH CHEMOTHERAPY IN ADOLESCENTS AND YOUNG ADULTS (AYAS) WITH STAGE III OR IV HODGKIN LYMPHOMA: A SUBGROUP ANALYSIS FROM THE PHASE 3 ECHELON‐1 STUDY

4. CALGB 50801 (ALLIANCE): PET ADAPTED THERAPY IN BULKY STAGE I/II CLASSIC HODGKIN LYMPHOMA (CHL)

5. Bortezomib consolidation or maintenance following immunochemotherapy and autologous stem cell transplantation for mantle cell lymphoma: CALGB /Alliance 50403

6. Three‐year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma

10. Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma

12. A phase 2 study of Rituximab-Bendamustine and Rituximab-Cytarabine for transplant-eligible patients with mantle cell lymphoma

13. Radiation for diffuse large B‐cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project

14. Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma

15. Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network

16. Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database

17. Improving the quality of bone marrow assessment

18. Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab

19. Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma

20. Prognostic factors for patients with diffuse large B cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation in the positron emission tomography era

21. Lack of benefit of central nervous system prophylaxis for diffuse large B-cell lymphoma in the rituximab era

23. Surveillance imaging of Hodgkin lymphoma patients in first remission

25. Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders

Catalog

Books, media, physical & digital resources